REFERENCES
- Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology 1983;90:458–474.
- Ozdemir H, Karacorlu M, Karacorlu S. Serous macular detachment in central retinal vein occlusion. Retina (Philadelphia, Pa) 2005;25:561–563.
- Tsujikawa A, Sakamoto A, Ota M et al. Serous retinal detachment associated with retinal vein occlusion. Am J Ophthalmol 2010;149:291–301.e5.
- Noma H, Funatsu H, Mimura T, Harino S, Hori S. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology 2009;116:87–93.
- Noma H, Funatsu H, Mimura T, Harino S, Hori S. Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion. Eur J Ophthalmol 2010;20:402–409.
- Noma H, Funatsu H, Mimura T, Harino S, Sone T, Hori S. Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular oedema and central retinal vein occlusion. Acta Ophthalmol 2010;88:646–651.
- Park SP, Ahn JK, Mun GH. Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion. Retina (Philadelphia, Pa) 2010;30:281–286.
- Tachi N, Hashimoto Y, Ogino N. Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol 1999;97:465–469.
- Leizaola-Fernández C, Suárez-Tatá L, Quiroz-Mercado H et al. Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases. BMC Ophthalmol 2005;5:10.
- Aiello LP, Avery RL, Arrigg PG et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480–1487.
- Thylefors B, Chylack LT Jr, Konyama K et al.; WHO Cataract Grading Group. A simplified cataract grading system. Ophthalmic Epidemiol 2002;9:83–95.
- 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17:151–183.
- Noma H, Funatsu H, Yamasaki M et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005;140:256–261.
- Noma H, Minamoto A, Funatsu H et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2006;244:309–315.
- Noma H, Funatsu H, Yamasaki M et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) 2008;22:42–48.
- The Central Vein Occlusion Study. Baseline and early natural history report. Arch Ophthalmol. 1993;111:1087–1095.
- The Central Vein Occlusion Study Group M report. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology. 1995;102:1425–1433.
- The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;115:486–491.
- Otani T, Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol 2000;129:487–494.
- Gaucher D, Sebah C, Erginay A et al. Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema. Am J Ophthalmol 2008;145:289–296.
- Weinberg D, Jampol LM, Schatz H, Brady KD. Exudative retinal detachment following central and hemicentral retinal vein occlusions. Arch Ophthalmol 1990;108:271–275.
- Ota M, Tsujikawa A, Kita M et al. Integrity of foveal photoreceptor layer in central retinal vein occlusion. Retina (Philadelphia, Pa) 2008;28:1502–1508.
- Otani T, Yamaguchi Y, Kishi S. Serous macular detachment secondary to distant retinal vascular disorders. Retina (Philadelphia, Pa) 2004;24:758–762.
- McAllister IL, Vijayasekaran S, Chen SD, Yu DY. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion. Am J Ophthalmol 2009;147:838–46, 846.e1.
- Ebrahem Q, Minamoto A, Hoppe G, Anand-Apte B, Sears JE. Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors. Invest Ophthalmol Vis Sci 2006;47:4935–4941.
- Brown DM, Campochiaro PA, Singh RP et al. CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1124–1133.e1.